Free Trial

Globus Medical Q1 2023 Earnings Report

Globus Medical logo
$85.07 +1.65 (+1.98%)
(As of 12:34 PM ET)

Globus Medical EPS Results

Actual EPS
$0.53
Consensus EPS
$0.51
Beat/Miss
Beat by +$0.02
One Year Ago EPS
$0.42

Globus Medical Revenue Results

Actual Revenue
$276.90 million
Expected Revenue
$254.05 million
Beat/Miss
Beat by +$22.85 million
YoY Revenue Growth
+20.10%

Globus Medical Announcement Details

Quarter
Q1 2023
Time
After Market Closes

Conference Call Resources

Conference Call Audio

URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

>> Register for the Workshop Now

Globus Medical Earnings Headlines

Globus Medical (GMED) Gets a Buy from Roth MKM
This Crypto Is Set to Explode in December
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
Analysts Offer Predictions for Globus Medical Q3 Earnings
BTIG Sticks to Their Buy Rating for Globus Medical (GMED)
See More Globus Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Globus Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Globus Medical and other key companies, straight to your email.

About Globus Medical

Globus Medical (NYSE:GMED), a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

View Globus Medical Profile

More Earnings Resources from MarketBeat

Upcoming Earnings